journal article·2024-04-10

Proton Sponge Nanocomposites for Synergistic Tumor Elimination via Autophagy Inhibition-Promoted Cell Apoptosis and Macrophage Repolarization-Enhanced Immune Response

Yifan Duan, Wei Zhang, Yi Ouyang, Qiang Yang, Qiuye Zhang, Sheng Zhao, Chunmei Chen, Ting Xu, Qun Zhang, Haitao Ran, Hui Liu

ACS Applied Materials & Interfaces· Volume 16· Issue 14
Publisher page

Abstract

Cytoprotective autophagy and an immunosuppressive tumor microenvironment (TME) are two positive promoters for tumor proliferation and metastasis that severely hinder therapeutic efficacy. Inhibiting autophagy and reconstructing TME toward macrophage activation simultaneously are of great promise for effective tumor elimination, yet are still a huge challenge. Herein, a kind of dendrimer-based proton sponge nanocomposites was designed and constructed for tumor chemo/chemodynamic/immunotherapy through autophagy inhibition-promoted cell apoptosis and macrophage repolarization-enhanced immune response. These obtained nanocomposites contain a proton sponge G5AcP dendrimer, a Fenton-like agent Cu(II), and chemical drug doxorubicin (DOX). When accumulated in tumor regions, G5AcP can act as an immunomodulator to realize deacidification-promoted macrophage repolarization toward antitumoral type, which then secretes inflammatory cytokines to activate T cells. They also regulate intracellular lysosomal pH to inhibit cytoprotective autophagy. The released Cu(II) and DOX can induce aggravated damage through a Fenton-like reaction and chemotherapeutic effect in this autophagy-inhibition condition. Tumor-associated antigens are released from these dying tumor cells to promote the maturity of dendritic cells, further activating T cells. Effective tumor elimination can be achieved by this dendrimer-based therapeutic strategy, providing significant guidance for the design of a promising antitumor nanomedicine.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Autophagy in Disease and Therapy · Immune cells in cancer · Phagocytosis and Immune Regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Luminescence Analysis and Molecular Sensing (Southwest University), Ministry of Education, School of Materials and Energy, Southwest University, Chongqing 400715, China

Chongqing Key Laboratory of Ultrasound Molecular Imaging, Institute of Ultrasound Imaging, Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China

Office of Clinical Trial of Drug, Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, Guangdong, China

Funding

Chongqing Municipal Education Commission · Natural Science Foundation of Chongqing Municipality · Guangzhou Municipal Science and Technology Bureau · National Natural Science Foundation of China

References (64)

Show source-provided references
1. 10.1002/anie.20200190610.1002/anie.202001906 ↗
2. 10.1186/s12951-022-01247-610.1186/s12951-022-01247-6 ↗
3. 10.1016/j.cej.2022.13679510.1016/j.cej.2022.136795 ↗
4. 10.1016/j.cej.2022.14045510.1016/j.cej.2022.140455 ↗
5. 10.1002/smll.20190107310.1002/smll.201901073 ↗
6. 10.1016/j.actbio.2023.07.01810.1016/j.actbio.2023.07.018 ↗
7. 10.1158/1078-0432.CCR-11-081610.1158/1078-0432.CCR-11-0816 ↗
8. 10.1016/j.biomaterials.2021.12089110.1016/j.biomaterials.2021.120891 ↗
9. 10.1038/nature2081510.1038/nature20815 ↗
10. 10.1023/A:100805803151110.1023/A:1008058031511 ↗
11. 10.1158/0008-5472.CAN-16-197010.1158/0008-5472.CAN-16-1970 ↗
12. 10.1016/j.yexcr.2021.11267810.1016/j.yexcr.2021.112678 ↗
13. 10.1016/j.biomaterials.2019.11966810.1016/j.biomaterials.2019.119668 ↗
14. 10.3390/cancers1406146210.3390/cancers14061462 ↗
15. 10.1002/cncr.3133510.1002/cncr.31335 ↗
16. 10.1126/sciadv.abb872510.1126/sciadv.abb8725 ↗
17. 10.1038/s41467-018-03225-910.1038/s41467-018-03225-9 ↗
18. 10.1021/acs.nanolett.1c0282510.1021/acs.nanolett.1c02825 ↗
19. 10.1016/j.nantod.2023.10193610.1016/j.nantod.2023.101936 ↗
20. 10.1002/advs.20190332310.1002/advs.201903323 ↗
21. 10.1158/2159-8290.CD-19-029210.1158/2159-8290.CD-19-0292 ↗
22. 10.1016/j.cclet.2020.03.00110.1016/j.cclet.2020.03.001 ↗
23. 10.1016/j.intimp.2016.01.02310.1016/j.intimp.2016.01.023 ↗
24. 10.1016/j.apsb.2020.05.00810.1016/j.apsb.2020.05.008 ↗
25. 10.1111/imm.1264710.1111/imm.12647 ↗
26. 10.1016/j.immuni.2014.06.01010.1016/j.immuni.2014.06.010 ↗
27. 10.1016/j.ejphar.2020.17309010.1016/j.ejphar.2020.173090 ↗
28. 10.1002/adma.20200806510.1002/adma.202008065 ↗
29. 10.1200/JCO.2014.59.435810.1200/JCO.2014.59.4358 ↗
30. 10.1002/advs.20200274610.1002/advs.202002746 ↗
31. 10.1021/acsnano.1c0276510.1021/acsnano.1c02765 ↗
32. 10.1021/acsnano.0c1039610.1021/acsnano.0c10396 ↗
33. 10.1021/acsnano.2c0046210.1021/acsnano.2c00462 ↗
34. 10.1002/adfm.20190928510.1002/adfm.201909285 ↗
35. 10.1002/adma.20220686110.1002/adma.202206861 ↗
36. 10.1002/adma.20210700910.1002/adma.202107009 ↗
37. 10.1016/j.ccr.2020.21346310.1016/j.ccr.2020.213463 ↗
38. 10.1016/j.jconrel.2023.01.07610.1016/j.jconrel.2023.01.076 ↗
39. 10.1021/acs.nanolett.1c0303110.1021/acs.nanolett.1c03031 ↗
40. 10.1021/am500761x10.1021/am500761x ↗
41. 10.1002/smll.20200566110.1002/smll.202005661 ↗
42. 10.1002/adfm.20191024910.1002/adfm.201910249 ↗
43. 10.1002/anie.20210174410.1002/anie.202101744 ↗
44. 10.1016/j.nantod.2021.10132510.1016/j.nantod.2021.101325 ↗
45. 10.1002/adhm.20210041210.1002/adhm.202100412 ↗
46. 10.1016/j.biomaterials.2021.12096210.1016/j.biomaterials.2021.120962 ↗
47. 10.1002/adfm.20180002510.1002/adfm.201800025 ↗
48. 10.1126/sciadv.abb311610.1126/sciadv.abb3116 ↗
49. 10.1021/acs.nanolett.0c0477810.1021/acs.nanolett.0c04778 ↗
50. 10.1038/s41467-020-18745-610.1038/s41467-020-18745-6 ↗
51. 10.1021/acsnano.2c0801310.1021/acsnano.2c08013 ↗
52. 10.1021/acs.accounts.9b0039710.1021/acs.accounts.9b00397 ↗
53. 10.1016/j.biomaterials.2021.12116810.1016/j.biomaterials.2021.121168 ↗
54. 10.1021/acsami.0c1258010.1021/acsami.0c12580 ↗
55. 10.1002/adma.20190463910.1002/adma.201904639 ↗
56. 10.1002/adma.20200208510.1002/adma.202002085 ↗
57. 10.1021/acs.nanolett.1c0140110.1021/acs.nanolett.1c01401 ↗
58. 10.1021/acsnano.2c0268810.1021/acsnano.2c02688 ↗
59. 10.1021/acsnano.0c1076410.1021/acsnano.0c10764 ↗
60. 10.1021/acsnano.2c0359710.1021/acsnano.2c03597 ↗
61. 10.1002/adma.20170345810.1002/adma.201703458 ↗
62. 10.1016/j.jdermsci.2004.03.00210.1016/j.jdermsci.2004.03.002 ↗
63. 10.1007/s13402-018-0376-610.1007/s13402-018-0376-6 ↗
64. 10.3390/ijms2009227210.3390/ijms20092272 ↗